ARK Invest
Asset managerPortfolio in United States: 2 funded startups tracked by Uback, 2 of them in a ranking.
Portfolio on Uback2startups, 1 country
In a ranking2ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedNov 2025Iambic Therapeutics
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Iambic Therapeutics | #7 AI drug discovery | Healthtech › Biotech › AI drug discovery | Equity round · over USD 100M · Nov 2025 | Unicorn |
| Umoja Biopharma | #10 Gene & cell therapies | Healthtech › Biotech › Gene & cell therapies | Series C · USD 100M · Jan 2025 | Hundreds of M$ |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
22025
Co-investors
Sequoia Capital · Regeneron · Mubadala · Qatar Investment Authority · Alexandria Venture Investments · Cormorant · SoftBank
Investors that joined the same rounds, as reported by public sources.
Sources. bioxconomy.com, businesswire.com, forgeglobal.com, labiotech.eu, as cited on each company’s profile.
Last updated: Sep 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.